Check out the companies making headlines for noon deals. Tesla – Elon Musk’s EV Company has seen its stock slide another 3.9%, bringing a monthly date loss to a whopping 23%. The sale comes after Tesla’s Chinese rival Zeekr said it was rolling out an advanced driver assistance system for free. Meanwhile, RBC Capital Markets has lowered Tesla’s price target amid declining expectations regarding the price of the company’s autonomous driving capabilities. Alphabet – Google’s parent stocks have slid 2.7%. Google said Tuesday it signed a decisive agreement to win a full-speed cash deal for Cloud Security Startup Wiz for $32 billion. The deal is set to be Google’s biggest acquisition ever. PALANTIR – The stock slipped 2.4%, bringing monthly losses to about 6%. Jeffries also reiterated that its stock in defense technology is inadequate, saying the valuation remains a concern. NVIDIA – CHIPMaker stepped back 1.7% ahead of CEO Jensen Fan’s keynote speech at the GTC AI conference. After the Lucid-Morgan Stanley upgrade was upgraded from underweight to equal weight, electric vehicle inventory rose 14%. Morgan Stanley said lucid has an emerging bull case linked to artificial intelligence. Sarepta Therapeutics – The biotechnology company plummeted 20% after disclosing the death of a man treated with elevedi gene therapy. In a statement, Salepta said acute liver damage is a known potential side effect. Eastman Kodak – Stock in film and chemical makers fell 4.6% after reporting fourth quarter results. Eastman Kodak recorded consolidated revenue of $266 million, reflecting a 3% decline, compared to $275 million in the fourth quarter of 2023. The company reported a surge in net profit for the fourth quarter, but generated net profit of $26 million in quarter. This is up from $5 million in the same period last year. Peabody Energy – The coal mining company has risen 3.7% by 3.7% after President Donald Trump wrote about social media platform Truth Social. Willis Tower Watson – Commercial insurance stocks rose 2% to buy from neutral right after UBS upgrades. UBS said the company has improved its operating and free cash flow margins faster than its peers. Millrose Properties – After the company declared dividends and issued new guidance, the residential land developers popped nearly 10%. Millrose pays shareholders 38 cents per share. It added that it will see second quarter revenues between 65 cents and 68 cents per share. HIMS & HERS Health – Digital health stock fell by 8% after the Food and Drug Administration shared concerns about unauthorized GLP-1 drugs used for weight loss, including combined versions. Hims & Hers began prescribing compound semaglutide last year. – CNBC’s Brian Evans, Pier Singh, Yun Lee and Fred Inbert contributed the report.
